Back to search

PSA markers in prostate cancer detection

Data up to Jan 2025

Published2003
Citations100
References88

Total Citations Per Year

Abstract

References (88)

Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men

1994 • 1,171 citations

Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease

1998 • 1,148 citations

Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges

1993 • 1,118 citations

A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.

1991 • 954 citations

Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin

1991 • 947 citations

Prostate Cancer Detection in a Clinical Urological Practice by Ultrasonography, Digital Rectal Examination and Prostate Specific Antigen

1990 • 767 citations

A Prospective Evaluation of Plasma Prostate-Specific Antigen for Detection of Prostatic Cancer

1995 • 735 citations

Prostate Cancer Detection in Men With Serum PSA Concentrations of 2.6 to 4.0 ng/mL and Benign Prostate Examination

1997 • 675 citations

Biology of Prostate-Specific Antigen

2003 • 673 citations

Enzymatic activity of prostate‐specific antigen and its reactions with extracellular serine proteinase inhibitors

1990 • 663 citations

Serum Prostate Specific Antigen Complexed toα1-Antichymotrypsin as an Indicator of Prostate Cancer

1993 • 660 citations

Screening for Prostatic Carcinoma with Prostate Specific Antigen

1992 • 631 citations

PROSTATE SPECIFIC ANTIGEN: A DECADE OF DISCOVERY-WHAT WE HAVE LEARNED AND WHERE WE ARE GOING

1999 • 618 citations

Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging

2000 • 331 citations

PROSTATE CANCER DETECTION AT LOW PROSTATE SPECIFIC ANTIGEN

2000 • 323 citations

OPTIMAL PREDICTORS OF PROSTATE CANCER ON REPEAT PROSTATE BIOPSY: A PROSPECTIVE STUDY OF 1,051 MEN

2000 • 321 citations

Selection of Optimal Prostate Specific Antigen Cutoffs for Early Detection of Prostate Cancer: Receiver Operating Characteristic Curves

1994 • 318 citations

Molecular forms of prostate-specific antigen and the human kallikrein gene family: A new era

1995 • 317 citations

Comparison of Prostate Specific Antigen Concentration Versus Prostate Specific Antigen Density in the Early Detection of Prostate Cancer: Receiver Operating Characteristic Curves

1994 • 270 citations

Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: Influence of total psa, prostate volume, and age

1996 • 255 citations

Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease.

1992 • 242 citations

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer

1995 • 206 citations

INTERPRETATION OF FREE PROSTATE SPECIFIC ANTIGEN CLINICAL RESEARCH STUDIES FOR THE DETECTION OF PROSTATE CANCER

1998 • 204 citations

Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age

1994 • 196 citations

A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer.

2001 • 194 citations

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

1997 • 192 citations

Free prostate-specific antigen in serum is becoming more complex

2002 • 191 citations

Prostate-specific antigen in milk of lactating women

1995 • 186 citations

Diagnosis of Prostatic Carcinoma: The Yield of Serum Prostate Specific Antigen, Digital Rectal Examination and Transrectal Ultrasonography

1994 • 184 citations

Purification and characterization of different molecular forms of prostate-specific antigen in human seminal fluid

1995 • 178 citations

Complex formation between protein C inhibitor and prostate‐specific antigen in vitro and in human semen

1994 • 178 citations

NONPROSTATIC SOURCES OF PROSTATE-SPECIFIC ANTIGEN

1997 • 178 citations

“BPSA,” a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia

2000 • 174 citations

PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL

1999 • 171 citations

A precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serum

1997 • 162 citations

COMPLEXED PROSTATE SPECIFIC ANTIGEN PROVIDES SIGNIFICANT ENHANCEMENT OF SPECIFICITY COMPARED WITH TOTAL PROSTATE SPECIFIC ANTIGEN FOR DETECTING PROSTATE CANCER

2000 • 149 citations

PSA density (PSAD). Role in patient evaluation and management.

1993 • 146 citations

Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate

1994 • 144 citations

CHARACTERISTICS OF SCREENING DETECTED PROSTATE CANCER IN MEN 50 TO 66 YEARS OLD WITH 3 TO 4 NG./ML. PROSTATE SPECIFIC ANTIGEN

1998 • 141 citations

Prostate‐Specific antigen expression by various tumors

1995 • 138 citations

Prostate cancer trends in the era of prostate-specific antigen

2002 • 136 citations

Complexed Prostate Specific Antigen Improves Specificity for Prostate Cancer Detection: Results of a Prospective Multicenter Clinical Trial

2003 • 128 citations

Determination of the “reflex range” and appropriate cutpoints for percent free prostatespecific antigen in 413 men referred for prostatic evaluation using the AxSYM system

1997 • 125 citations

Proenzyme psa for the early detection of prostate cancer in the 2.5–4.0 ng/ml total psa range: preliminary analysis

2003 • 123 citations

Identification of precursor forms of free prostate-specific antigen in serum of prostate cancer patients by immunosorption and mass spectrometry.

2001 • 121 citations

Novel immunoassay for the measurement of complexed prostate-specific antigen in serum.

1998 • 113 citations

Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial

2002 • 112 citations

The Use of Age-Specific Reference Ranges for Serum Prostate Specific Anitgen in Men 60 years Old or Older

1995 • 109 citations

The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia

1997 • 106 citations

Prostate-specific antigen immunoreactivity in amniotic fluid

1995 • 102 citations

PSA DENSITY (PSAD)

1993 • 99 citations

Discrimination of Prostate Cancer from Benign Disease by Plasma Measurement of Intact, Free Prostate-specific Antigen Lacking an Internal Cleavage Site at Lys145-Lys146

2001 • 99 citations

Novel immunoassay for the measurement of complexed prostate-specific antigen in serum

1998 • 96 citations

USE OF LOWER PROSTATE SPECIFIC ANTIGEN CUTOFFS FOR PROSTATE CANCER SCREENING IN BLACK AND WHITE MEN

1998 • 93 citations

Original Articles: Prostate Cancer: Measurement of Serum Prostate Specific Antigen Levels in Women and in Prostatectomized Men With an Ultrasensitive Immunoassay Technique

1995 • 90 citations

Rapid Exponential Elimination of Free Prostate-Specific Antigen Contrasts the Slow, Capacity-Limited Elimination of PSA Complexed to Alpha1-Antichymotrypsin From Serum

1998 • 81 citations

Prevalence and Pathological Extent of Prostate Cancer in Men with Prostate Specific Antigen Levels of 2.9 to 4.0 NG./ML.

1993 • 77 citations

Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter

2002 • 75 citations

Prospective evaluation of percent free-PSA and complexed-PSA for early detection of prostate cancer

1998 • 74 citations

Production and Characterization of Novel Anti-Prostate-specific Antigen (PSA) Monoclonal Antibodies That Do Not Detect Internally Cleaved Lys145-Lys146 Inactive PSA

2000 • 69 citations

PROSTATIC VOLUME AND RATIO OF FREE-TO-TOTAL PROSTATE SPECIFIC ANTIGEN IN PATIENTS WITH PROSTATIC CANCER OR BENIGN PROSTATIC HYPERPLASIA

1997 • 56 citations

Discrimination of Benign From Malignant Prostatic Disease by Selective Measurements of Single Chain, Intact Free Prostate Specific Antigen

2002 • 56 citations

Evaluation of common breast problems: guidance for primary care providers

1998 • 55 citations

Original Articles

1995 • 54 citations

PROSPECTIVE DETECTION OF CLINICALLY RELEVANT PROSTATE CANCER IN THE PROSTATE SPECIFIC ANTIGEN RANGE 1 TO 3 NG./ML. COMBINED WITH FREE-TO-TOTAL RATIO 20% OR LESS: THE AARAU EXPERIENCE

2001 • 52 citations

A guide to the interpretation of serum prostate specific antigen levels

1995 • 51 citations

Complexed prostate-specific antigen and its volume indexes in the detection of prostate cancer

1999 • 50 citations

Prostate-Specific Antigen: Critical Issues for the Practicing Physician

1994 • 49 citations

Different proportions of various prostate-specific antigen (PSA) and human kallikrein 2 (hK2) forms are present in noninduced and androgen-induced LNCaP cells

2000 • 47 citations

Comparison of two investigative assays for the complexed prostate-specific antigen in total prostate-specific antigen between 4.1 and 10.0 ng/mL

2000 • 47 citations

An artificial neural network considerably improves the diagnostic power of percent free prostate‐specific antigen in prostate cancer diagnosis: Results of a 5‐year investigation

2002 • 47 citations

Clearance rate of serum-free and total PSA following radical retropubic prostatectomy

1996 • 43 citations

Free/total PSA ratio improves differentiation of benign and malignant disease of the prostate: critical analysis of two different test populations

1999 • 41 citations

Cost-benefit analysis of total, free/total, and complexed prostate-specific antigen for prostate cancer screening

2002 • 33 citations

Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: which is clinically effective and when?

2000 • 33 citations

Prostate specific antigen density in patients with histologically proven prostate carcinoma

1994 • 32 citations

Clinical Evaluation of Serum Prostate‐Specific Antigen‐Alpha1 ‐ Antichymotrypsin Complex Values in Diagnosis of Prostate Cancer: A Cooperative Study

1998 • 28 citations

Probability of prostate cancer detection based on results of a multicenter study using the AxSYM free PSA and total PSA assays

2000 • 28 citations

Substratification of stage T1C prostate cancer based on the probability of biochemical recurrence

2002 • 28 citations

Significance of Free to Total PSA Ratio in Men with Slightly Elevated Serum PSA Levels: A Cooperative Study

1998 • 25 citations

The clinical usefulness of percent free-PSA

1996 • 24 citations

Development of an immunoassay specific for the PSA-ACT complex without the problem of high background

1998 • 23 citations

Regulation of the enzymatic activity of prostate-specific antigen and its reactions with extracellular protease inhibitors in prostate cancer.

1995 • 21 citations

Clinical Aspects of Prostate Cancer: Assessment of New Diagnostic and Management Procedures

1989 • 20 citations

Elimination of Serum Free and Total Prostate-Specific Antigen after Radical Retropubic Prostatectomy

1997 • 19 citations

A Gap Between Total Prostate-specific Antigen and the Sum of Free Prostate-specific Antigen Plus α1-Antichymotrypsin-Prostate-specific Antigen in Patients with Prostate Carcinoma but not in Those with Benign Prostate Hyperplasia

1999 • 18 citations

Bayer immuno 1™ PSA assay: An automated, ultrasensitive method to quantitate total PSA in serum

1998 • 12 citations

A comparison of three free and total PSA assays

1998 • 11 citations

Cited By (0)

No citing papers found in database

PSA markers in prostate cancer detection (2003) – Urologic Clinics of North America | Metascience Observatory Explorer